PIMCO Active Bond Exchange-Traded Fund BOND
87.97 USD +0.25 (+0.28%)
Regular-session close
87.78 -0.19 -0.22%
After hours · Nov 18, 6:51 PM ET
87.75 Day range 88.00
86.39 52-week range 94.61
- YTD
- -5.49%
- 1 year
- -5.76%
News
etftrends.com PIMCO & Guggenheim Talk Fixed Income Opportunities for 2027 Given just how much macroeconomic conditions have been shifting in recent months, how should advisors and investors be approaching yield opportunities in the coming days? Key Takeaways: PIMCO's Brian…
defenseworld.net Sowell Financial Services LLC Purchases 5,667 Shares of Pimco Total Return ETF $BOND Sowell Financial Services LLC acquired a new stake in Pimco Total Return ETF (NYSE: BOND) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission…
defenseworld.net Fifth Third Securities Inc. Purchases New Position in Pimco Total Return ETF $BOND Fifth Third Securities Inc. purchased a new stake in Pimco Total Return ETF (NYSE: BOND) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission…
defenseworld.net Centerline Wealth Advisors LLC Sells 22,193 Shares of Pimco Total Return ETF $BOND Centerline Wealth Advisors LLC lessened its holdings in shares of Pimco Total Return ETF (NYSE: BOND) by 73.6% in the undefined quarter, according to its most recent filing with the SEC. The fund…
gurufocus.com Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1 Takeda ([url="]TSE:4502/NYSE: TAK[/url])announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (N
defenseworld.net 24,790 Shares in Pimco Total Return ETF $BOND Bought by Forvis Mazars Wealth Advisors LLC Forvis Mazars Wealth Advisors LLC purchased a new stake in Pimco Total Return ETF (NYSE: BOND) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange…
defenseworld.net Fragasso Financial Advisors Inc Buys New Position in Pimco Total Return ETF $BOND Fragasso Financial Advisors Inc bought a new stake in shares of Pimco Total Return ETF (NYSE: BOND) during the third quarter, according to the company in its most recent disclosure with the…
etftrends.com The $15 Billion Club: Active Income Strategies Two popular ETFs crossed the $15 billion in assets mark last week. The JPMorgan Core Plus Bond ETF (JCPB) and the NEOS Nasdaq 100 High Income ETF (QQQI).
prnewswire.com T. ROWE PRICE LAUNCHES DYNAMIC EMERGING MARKETS BOND EXCHANGE TRADED FUND BALTIMORE, Oct. 1, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of the T. Rowe Price Dynamic Emerging Markets Bond…
defenseworld.net Pimco Total Return ETF $BOND Shares Bought by Bank of New York Mellon Corp Bank of New York Mellon Corp lifted its stake in shares of Pimco Total Return ETF (NYSEARCA:BOND) by 43.8% during the first quarter, according to the company in its most recent disclosure with the…
defenseworld.net Avior Wealth Management LLC Sells 10,349 Shares of Pimco Total Return ETF $BOND Avior Wealth Management LLC trimmed its position in shares of Pimco Total Return ETF (NYSEARCA:BOND) by 27.4% during the undefined quarter, according to the company in its most recent 13F filing with…
seekingalpha.com BOND: The Seas Are Changing Once Again BOND earns a Buy rating for its conservative risk profile and consistent inflation-beating returns. BOND benefits from active management, allowing nimble allocation into agency MBS and…
globenewswire.com CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology Data reinforce durable responses, bladder preservation, low rate of disease progression, and favorable safety and tolerability in patients with high-risk, BCG-unresponsive non-muscle invasive bladder…
gurufocus.com Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy PR New
seekingalpha.com BOND: An Intermediate Active Fixed Income Allocation In A Relatively Attractive Environment Pimco Active Bond ETF offers an interesting fixed income allocation with a ~5.17% SEC yield and active management. BOND's active approach is well-suited for today's uncertain interest rate…
etftrends.com Navigate Fixed Income with PIMCO's Active ETF Trio Higher-for-longer interest rates and a new Federal Reserve chair confirmation are only adding to the market uncertainty in fixed income. With that, active management has almost become a necessity…
247wallst.com If Treasury Yields Spike Above 4.6%, This Is What Happens to JBND Active ETFs captured 84% of all U.S. ETF launches in 2025, and nowhere does that shift matter more than in fixed income.
247wallst.com HIMU Sits Vulnerable to a Double Risk: Slowing Growth and Stuck Interest Rates The iShares High Yield Muni Active ETF (CBOE:HIMU) sits in one of the more specialized corners of the bond market: actively managed, below-investment-grade and non-rated municipal debt, wrapped in an…
247wallst.com 100 Mutual Fund Conversions Are Coming: Why BOND and FBND Could See Massive Inflows This Year The active bond ETF wrapper is about to absorb a structural shift. the PIMCO Active Bond ETF (NYSEARCA:BOND | BOND Price Prediction) sits near $92 after a 6% total return over the past year, while…
fool.com Brookwood Cuts FLXR Position by $3 Million -- What Income Investors Should Know FLXR is a Los Angeles-based ETF targeting high current income with a flexible, multi-sector strategy and daily liquidity for investors.
